Gritstone Bio Can Tap $25M New DIP As It Works Toward Sale
Vaccine developer Gritstone bio Inc. won a Delaware bankruptcy judge's approval Wednesday to borrow $25 million in new financing to support itself in Chapter 11 as the biotechnology company works to...To view the full article, register now.
Already a subscriber? Click here to view full article